Intelgenx Technologies (FRA:0IL) Additional Paid-In Capital : €63.72 Mil(As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Intelgenx Technologies Additional Paid-In Capital?

Intelgenx Technologies's quarterly additional paid-in capital declined from Sep. 2023 (€64.03 Mil) to Dec. 2023 (€62.96 Mil) but then increased from Dec. 2023 (€62.96 Mil) to Mar. 2024 (€63.72 Mil).

Intelgenx Technologies's annual additional paid-in capital increased from Dec. 2021 (€55.85 Mil) to Dec. 2022 (€63.57 Mil) but then declined from Dec. 2022 (€63.57 Mil) to Dec. 2023 (€62.96 Mil).

Intelgenx Technologies Additional Paid-In Capital Historical Data

The historical data trend for Intelgenx Technologies's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intelgenx Technologies Additional Paid-In Capital Chart

Intelgenx Technologies Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

38.37

39.83

55.85

63.57

62.96

Intelgenx Technologies Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Additional Paid-In Capital	Get a 7-Day Free Trial															62.92	62.34	64.03	62.96	63.72

Intelgenx Technologies Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Intelgenx Technologies Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Intelgenx Technologies's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Intelgenx Technologies (FRA:0IL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Intelgenx Technologies Corp (FRA:0IL) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

IGXT:USA IGX:Canada

Address

6420 Abrams, Ville Saint Laurent, QC, CAN, H4S 1Y2

Website

https://www.intelgenx.com

Intelgenx Technologies Corp is an oral drug delivery company. The company is focused on the development and manufacturing of pharmaceutical oral films based on its proprietary VersaFilmTM technology platform. Intelegenx focuses on the development of novel oral immediate-release and controlled-release products for the pharmaceutical market. It offers a comprehensive portfolio of pharmaceutical services, including pharmaceutical R&D, clinical monitoring, regulatory support, tech transfer and manufacturing scale-up, and commercial manufacturing. Its geographical segments are Europe, Canada, and United States.

Intelgenx Technologies (FRA:0IL) Headlines

No Headlines